Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases
- PMID: 18460981
- DOI: 10.1097/PAS.0b013e318164edf7
Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases
Abstract
There are conflicting data about chemoresistance and prognosis in ovarian clear cell carcinoma (CCC). This could be due to significant interobserver variation in the diagnosis of CCC and other ovarian surface epithelial tumors containing clear cells. Thirty-two cases previously diagnosed as CCC, high-grade ovarian serous carcinoma (SC), and mixed surface epithelial carcinoma (SEC) with clear cell and serous components were reviewed by 4 gynecologic pathologists blinded to the original diagnoses. Interobserver reproducibility was evaluated. Each case was also assessed using immunohistochemical markers Wilm tumor 1, estrogen receptor, and p53. The interobserver reproducibility was greatest for pure CCC (kappa of 0.82), and lowest for the mixed SEC (kappa of 0.32). Moderate agreement was seen in the pure SC category (kappa of 0.59). All pure SC and most mixed SEC presented as stage III or IV diseases. Most pure CCC presented as stage I or II diseases. Immunoreactivities of the mixed SECs were similar to those of pure SC, but significantly different from those of pure CCC for Wilm tumor 1 (P=0.0011 for both components), estrogen receptor (P=0.0003 for clear cell component, P=0.0001 for serous component), and p53 (P=0.0062 for both components). The serous and clear cell components of mixed SEC showed higher mitotic rates than pure CCC (P=0.004 and P=0.023, respectively), but the mitotic rate of pure SC was similar to the mixed SEC. We conclude that (1) pure CCC is reproducibly diagnosed. (2) The diagnosis of mixed ovarian SEC with clear cell component is not reproducible. (3) Mixed SEC with clear cell and serous components show similar stage, mitotic activities, and immunoreactivities to those of pure SC, and likely represent SC with clear cell changes.
Similar articles
-
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.Hum Pathol. 2008 Aug;39(8):1239-51. doi: 10.1016/j.humpath.2008.01.003. Epub 2008 Jul 7. Hum Pathol. 2008. PMID: 18602670
-
Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.Am J Surg Pathol. 2008 Feb;32(2):269-74. doi: 10.1097/PAS.0b013e31814fa9b0. Am J Surg Pathol. 2008. PMID: 18223330
-
[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17631760 Chinese.
-
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Pathology. 2011. PMID: 21716157 Review.
-
Histological classification of ovarian cancer.Med Electron Microsc. 2003 Mar;36(1):9-17. doi: 10.1007/s007950300002. Med Electron Microsc. 2003. PMID: 12658347 Review.
Cited by
-
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.Sci Rep. 2024 Aug 13;14(1):18797. doi: 10.1038/s41598-024-69796-4. Sci Rep. 2024. PMID: 39138354 Free PMC article.
-
Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.Diagn Pathol. 2016 Feb 2;11:17. doi: 10.1186/s13000-016-0467-5. Diagn Pathol. 2016. PMID: 26837693 Free PMC article.
-
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S40-S63. doi: 10.1097/PGP.0000000000000491. Int J Gynecol Pathol. 2019. PMID: 30550483 Free PMC article. Review.
-
HNF-1β in ovarian carcinomas with serous and clear cell change.Int J Gynecol Pathol. 2013 Nov;32(6):541-6. doi: 10.1097/PGP.0b013e318273fd07. Int J Gynecol Pathol. 2013. PMID: 24071869 Free PMC article.
-
Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study.BMC Womens Health. 2023 May 15;23(1):262. doi: 10.1186/s12905-023-02405-0. BMC Womens Health. 2023. PMID: 37189098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous